S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q3 2022

Deep Track Capital

Period: Q3 2022 Β· Filed: 2022-11-14
View on SEC EDGAR β†—
AUM
$2.18B
Total portfolio value
Positions
65
Reported securities
Top Holding
ISEE
5.8% $125.6M
QoQ Changes
+8 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ISEEIVERIC BIO INC$125.6M5.75%β€”β€”
5.8%
JAZZJAZZ PHARMACEUTICALS PLC$114.8M5.26%$133.29$243.47+82.7%
5.3%
ASNDCALLASCENDIS PHARMA A/S$103.3M4.73%$103.26$274.50+165.8%
4.7%
TVTXTRAVERE THERAPEUTICS INC$98.6M4.51%$24.64$56.92+131.0%
4.5%
NVCRNOVOCURE LTD$98.3M4.50%$75.98$17.20-77.4%
4.5%
HZNPHORIZON THERAPEUTICS PUB L$90.5M4.15%β€”β€”
4.2%
ASNDASCENDIS PHARMA A/S$82.6M3.78%$103.26$274.50+165.8%
3.8%
SWTXSPRINGWORKS THERAPEUTICS INC$67.6M3.10%β€”β€”
3.1%
BCYCBICYCLE THERAPEUTICS PLC$67.5M3.09%$23.26$4.35-81.3%
3.1%
BMRNBIOMARIN PHARMACEUTICAL INC$62.6M2.87%$84.77$58.99-30.4%
2.9%
KDNYCHINOOK THERAPEUTICS INC$59.0M2.70%β€”β€”
2.7%
IMVTIMMUNOVANT INC$55.0M2.52%$5.58$38.79+595.2%
2.5%
AGENAGENUS INC$54.0M2.47%$40.24$3.49-91.3%
2.5%
BEAMBEAM THERAPEUTICS INC$47.6M2.18%$47.64$34.79-27.0%
2.2%
KURAKURA ONCOLOGY INC$43.5M1.99%$13.66$11.10-18.7%
2.0%
AUPHAURINIA PHARMACEUTICALS INC$42.7M1.96%$7.52$15.61+107.6%
2.0%
DYNDYNE THERAPEUTICS INC$40.4M1.85%$12.70$23.07+81.7%
1.9%
VRDNVIRIDIAN THERAPEUTICS INC$40.4M1.85%$20.51$19.40-5.4%
1.9%
RPTXREPARE THERAPEUTICS INC$37.9M1.74%β€”β€”
1.7%
ABOSACUMEN PHARMACEUTICALS INC$37.9M1.74%$10.03$2.74-72.7%
1.7%
ESPRESPERION THERAPEUTICS INC NE$37.8M1.73%$6.70$3.16-52.8%
1.7%
NKTXNKARTA INC$37.0M1.70%$13.16$3.22-75.5%
1.7%
HRTXHERON THERAPEUTICS INC$36.1M1.65%$4.22$0.44-89.6%
1.6%
ISEECALLIVERIC BIO INC$35.9M1.64%β€”β€”
1.6%
EWTXEDGEWISE THERAPEUTICS INC$33.2M1.52%$9.84$39.56+302.0%
1.5%
FATEFATE THERAPEUTICS INC$29.4M1.35%$22.41$2.92-87.0%
1.4%
PLRXPLIANT THERAPEUTICS INC$29.2M1.34%$20.89$1.17-94.4%
1.3%
VRNAVERONA PHARMA PLC$28.9M1.32%β€”β€”
1.3%
ALLKALLAKOS INC$27.6M1.27%β€”β€”
1.3%
AKROAKERO THERAPEUTICS INC$26.9M1.23%β€”β€”
1.2%

Quarter-on-Quarter Activity

Q3 2022 vs. Q2 2022

New Positions (8)

TickerIssuerNotionalSince Filing
ASNDASCENDIS PHARMA A/S$103.3M+165.8%
HZNPHORIZON THERAPEUTICS PUB L$90.5M
ASNDASCENDIS PHARMA A/S$82.6M+165.8%
SWTXSPRINGWORKS THERAPEUTICS INC$67.6M
AUPHAURINIA PHARMACEUTICALS INC$42.7M+107.6%
HRTXHERON THERAPEUTICS INC$36.1M-89.6%
EWTXEDGEWISE THERAPEUTICS INC$33.2M+302.0%
PLRXPLIANT THERAPEUTICS INC$29.2M-94.4%

Exited Positions (7)

TickerIssuerNotional
ALNYALNYLAM PHARMACEUTICALS INC$72.9M
MDGLMADRIGAL PHARMACEUTICALS INC$64.8M
ACADACADIA PHARMACEUTICALS INC$24.4M
SAGESAGE THERAPEUTICS INC$5.5M
TNYATENAYA THERAPEUTICS INC$2.7M
PTGXPROTAGONIST THERAPEUTICS INC$2.1M
ATYRATYR PHARMA INC$0.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
VIGLVIGIL NEUROSCIENCE INC$20.7M+666.3%
SLNSILENCE THERAPEUTICS PLC$8.3M+105.1%
JAZZJAZZ PHARMACEUTICALS PLC$36.8M+72.2%+82.7%
VRDNVIRIDIAN THERAPEUTICS INC$26.9M+68.4%-5.4%
ISEECALLIVERIC BIO INC$82.3M+55.6%
ABOSACUMEN PHARMACEUTICALS INC$23.3M+21.9%-72.7%
AGENAGENUS INC$10.8M+18.4%-91.3%
RPTXREPARE THERAPEUTICS INC$0.1M+15.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
GRTSQGRITSTONE BIO INC$-4.0M-97.4%
GBTGLOBAL BLOOD THERAPEUTICS IN$-94.3M-91.0%
RLMDCALLRELMADA THERAPEUTICS INC$-5.2M-76.6%
FMTXFORMA THERAPEUTICS HLDGS INC$-8.6M-76.1%
TCDAQCALLTRICIDA INC$-18.4M-71.7%
SDGRSCHRODINGER INC$-10.6M-69.8%
KROSKEROS THERAPEUTICS INC$-11.1M-66.4%
TCDAQCALLTRICIDA INC$-14.1M-56.9%
← Back to Hedge Funds